RxRegimen check replace synthesize
Back to Library
FDA LABEL GENERIC: Benzalkonium MFR: Trifluent Pharma LLC

Tridergel 0.1 % Topical Gel

Drug Facts

Active Ingredients

Benzalkonium Chloride (0.1%)

Purpose

Antimicrobial

INDICATIONS AND USAGE

Indications for management of:

Stage 1-2 open wounds Superficial stasis ulcers Superficial diabetic skin ulcers Post-surgical incisions First and second-degree burns Cuts Abrasions and skin irritations

Warnings

For external use only.

When using this product avoid contact with eyes; rinse immediately with cool tap water if contact occurs.

Do not use more than the recommended dose or longer than prescribed without checking with your physician. Talk with your physician before you use any other medicines or cleansers on your skin. Ask your physician before prolonged sun exposure. If your symptoms do not improve or they worsen, contact your physician

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) immediately.

Directions

Clean the wound before each application Apply a thin layer of Tridergel™ wound care gel to the wound surface and skin immediately surrounding the wound Cover the wound as directed by your physician

Inactive Ingredients

Aloe Barbadensis Leaf Juice Extract, Aminomethyl Propanol, Butylparaben, Carbomer, Decyl Glucoside, Ethylparaben, Glycerin, Hydrolyzed Eggshell Membrane, Isobutylparaben, Methylparaben, Phenoxyethanol, Propylparaben, Purified Water, Sodium Hyaluronate.

QUESTIONS OR COMMENTS

CALL (210) 944-6920

PRINCIPAL DISPLAY PANEL - 29.6 mL Bottle Label

TRIFLUENT
PHARMA®

TRIDERGEL™
WOUND CARE GEL

BENZALKONIUM CHLORIDE

IN A GEL CONTAINING
TRANSFORMING GROWTH
FACTOR – β

NDC 73352-520-01

1.0 FL OZ (29.6 mL)

PRODUCT SHOULD BE ADMINISTERED
UNDER THE SUPERVISION OF A
LICENSED MEDICAL PRACTITIONER